NCT07373119Enrolling by invitation
Improving Frailty in Patients With Stable Ischemic Heart Disease
Impact of a Program Aimed at Improving Frailty in Patients With Stable Ischemic Heart Disease in Primary Care: Fragicor Study
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
The goal of this clinical trial is to improve the frailty in old patients who have a cardiac disease . Researchers will determine the improvement in the instability and the strength along twelve sessions based on guided exercises and mobility techniques made by physiotherapists. Research team will also evaluate the medications and diet, as well as laboratory and clinical tests.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 2 Dec 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- Diseases
- Coronary artery disease
- NCT number
- NCT07373119
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Oct 2025 to the primary completion date, 30 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Inability or refusal to provide informed consent (advanced dementia, severe psychiatric illness)
- Severe mobility-limiting conditions (Parkinson's disease, progressive neurological disorders, disabling joint disease)
- Recent (\<6 months) unstable angina, myocardial infarction, coronary revascularization or angioplasty
- Deep venous thrombosis or pulmonary embolism in the last 6 months
- Recent stroke (\<6 months)
- Heart failure in New York Heart Assocaition functional status (NYHA) III-IV
- Symptomatic valvular heart disease
Lab values
- Left ventricular ejection fraction \< 50%
Other
- Inability to perform protocol procedures
Who the study is looking for
- Age ≥ 70 years
- Diagnosis of coronary artery disease (International Classification Diseases (ICD)-10 I20-I25)
- Canadian Cardiovascular Society Class I
- Low cardiovascular risk according to exclusion criteria
Age in the registry: 70 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Primary Care Centers Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.